Medical injection device with gas evacuation
By introducing gas in the float automatic emptiation path in the injection device, the problem of degassing time and waste of liquid in the existing injection system is solved, and rapid gas emptiation without operator participation is achieved, improving injection accuracy and safety sex.
Patent Information
- Application Number
- CN202380031398.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-30
- Filing Date
- 2023-03-30
- Publication Date
- 2024-11-15
AI Technical Summary
Existing injection systems require operator participation during the degassing process, which takes a long time and poses a risk of wasting medical liquids, and the incomplete emptiation of the gas may affect injection accuracy and safety.
An injection device is designed to float in the drain path using a float, automatically discharge the air through gravity, and ensure that medical liquid does not enter the drain path through a sealed structure, ensuring that gas is trapped in the cavity below the float, Achieve rapid gas exhaust without operator participation.
It realizes rapid evacuation of gas in the injection system without relying on the operator, reduces medical liquid waste, and improves injection accuracy and safety.
Smart Images

Figure CN118973634A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates generally to the injection of medical fluids, and more particularly to injection devices for injecting medical fluids from medical fluid containers into medical tubes. Background Art
[0002] Injection devices are often used to inject medical fluids from medical fluid containers into medical tubes. For example, in 70% of CT scan diagnostic cases, medical fluids such as iodinated contrast media need to be injected. In about 70% of cases, this injection is performed using an automatic contrast media injector. An injection tube is required to connect the automatic injector to the patient.
[0003] Patent application number US13 / 453,335 (US Publication No. 20120209111) discloses a bladder syringe for a fluid delivery system, comprising a cylindrical body, a cap-bladder assembly, a plunger element placed in the cylindrical body, and a mounting assembly fastened to the cap-bladder assembly on the cylindrical body. The cylindrical body has a distal end and a proximal end and defines a through hole. The cap-bladder assembly is adapted to be connected to the distal end of the cylindrical body and comprises a cap body and a bladder. The cap body defines an inner cavity and a distal discharge pipe and is adapted to engage the distal end of the cylindrical body. A disc-shaped bladder is arranged in the internal cavity and generally comprises a central membrane portion. The plunger element is arranged in the through hole of the cylindrical body and is ventilated so that the space between the plunger element in the cylindrical body and the cap-bladder assembly can be emptied.
[0004] Patent application US10 / 986,416 (US Publication No. 20060249541) discloses a fluid dispensing device, which includes a bottle for receiving a fluid, a discharge pipe, and a pressurizing device connected between the bottle and the discharge pipe, the pressurizing device is used to pressurize the fluid and to force the fluid to flow through the discharge pipe without gravity. The pressurizing device includes a container connected between the bottle and the discharge pipe, a piston slidably accommodated in the container, and a moving device for moving the piston in a reciprocating motion in the container. For example, a motor is connected to the piston by a crank to move the piston in a reciprocating motion in the container.
[0005] Patent application US10 / 810,686 (US Publication No. 20050215850) discloses an injection pump comprising a syringe, a drive mechanism and a safety catch, the syringe comprising a plunger sliding in a body having a discharge port, the drive mechanism being connected to the syringe, comprising a barrel in which a piston mounted on an axis slides, the biasing device being operative to exert a urging force on the piston to drive the piston distally in the barrel, the safety catch initially preventing the biasing device from moving the piston, and the safety catch being removable to allow the biasing device to move the piston.
[0006] Figure 1 An example of an injection system 100 for injecting a medical fluid from a medical fluid container 104 into a common line 102 is shown. Those skilled in the art will appreciate that the medical fluid container 104 can be any type of container particularly suitable for containing medical fluids, such as, but not limited to, vials, bottles, plastic containers, and any type of container manufactured to contain medical fluids. The injection system 100 includes a first connector 106 configured to be connected to the medical fluid container 104, a syringe 108 to which an injection device 110 having a medical tube interface 112 is attached, a medical liquid supply line 114 configured to connect the first connector 106 to the medical tube interface 112 to supply the medical fluid to the injection device 110, and a common line 102 configured to be connected to the medical tube interface 112 and to a patient line 116 to inject the medical fluid into the patient line 116. More specifically, the first tube valve 130 connects the liquid supply line 114 to the common line 102 and allows passage to the common line 102 only under vacuum pressure. The common line 102 includes a second tube valve 140 located downstream of the first tube valve 130 and allows passage only toward the patient line 116. The injection device 110 generally includes a body defining an interior space, and a piston driven by a plunger rod, the piston being configured to move within the interior space to pump fluid into the interior space or push fluid out of the interior space.
[0007] In the depicted example, two different types of medical fluids are to be injected into the patient, and therefore, the injection system 100 is configured to be connected to two medical fluid containers 104 via two different first connectors 106 and two different medical fluid supply lines 114. However, the injection system 100 can be configured to inject only one type of medical fluid. For simplicity, since double injection only involves duplicating the features, the following description will be made with reference to a configuration in which only one type of medical fluid is injected. Here, "double injection" should be understood to refer to two injections.
[0008] Multi-patient practices are steadily gaining market share for economic and ecological reasons (less use of plastic). In so-called multi-patient practices, the plumbing arrangement for the injection system 100 has two very different parts: a day set 120 and a patient set 122. The patient set 122 is changed for each patient. The patient set 122 is generally used to limit the risk of cross infection between consecutive patients, thereby protecting the day set. Once installed and primed, the day set 120 remains connected to the power injector for several patient cases as long as the same medical fluid is injected. When it is necessary to change the medical fluid to be injected, the day set 120 is changed. The day set 120 includes a medical fluid supply line 114 connected to a medical fluid container 104 and a common line 102. The patient set 122 includes a patient line 116, which is supplied with medical fluid through the common line 102 and is connected to a catheter or needle for injecting the medical fluid into the patient.
[0009] When the injection system 100 is configured to inject a medical fluid into a patient, it is important to ensure that no gas is present in the tubing prior to injection. Injecting a gas, such as air, into a patient's blood vessel may result in a gas embolism, i.e., a blood vessel obstruction caused by one or more bubbles of air or other gas in the circulatory system. When the day assembly 120 or the patient assembly 116 is placed in place, the tube is filled with air. Therefore, the gas present in the tube must be evacuated prior to injection. Due to the length of the tube, a large amount of gas will be evacuated from the injection system 100.
[0010] In order to degas all the gas present in the injection system 100 before injection, the injection device 110 extracts or draws out the medical liquid from the medical liquid container 104, thereby filling the medical liquid supply line 114. The injection device 110 is now full of a mixture of medical liquid and gas. Then, the injection device 110 is positioned with the medical tube interface 112 facing upward so that the gas accumulates at the medical tube interface 112. It should be noted that the filling of the injection device 110 causes turbulence of the medical liquid, generating microbubbles in the medical liquid. Due to the high viscosity of the medical liquid (especially for contrast agents), it may take several minutes for the microbubbles to reach the medical tube interface 112. Therefore, it is usually waited for at least 2 or 3 minutes with the medical tube interface 112 facing upward. Then, by actuating the piston, the gas is emptied from the injection device 110 into the common pipeline 102 through the medical tube interface 112 still facing upward. Then, the medical liquid is injected into the common pipeline 102 for pushing the gas out of the common pipeline 102, thereby cleaning the injection system 100.
[0011] During an injection, it may occur that gas is present in the injection device 110. For example, evaporation of the medical liquid may generate gas. Moreover, some bubbles generated during the initial filling of the injection system 100 may be blocked in the tubing or against the walls of the injection device 110 and may not be evacuated during the initial degassing. As a result, during an injection, the injection device 110 is positioned with the medical tube interface 112 facing downward, so that any gas present in the injection device 110 will be trapped in the injection device 110 away from the medical tube interface 112 and will not be injected into the common line 102.
[0012] This approach has several disadvantages. First, the injection device 110 must be moved between two relative positions: the medical tube interface 112 is up or down. This requires the syringe 108 to be able to rotate. Second, this degassing takes a lot of time, and the injection system 100 must be monitored by the operator during the degassing. The operator must also assess the quality of the degassing and whether the degassing has been completed. As with every human interaction, the reliance on the operator may lead to errors. Third, the gas is pushed along the common pipeline 102 by the medical fluid that also leaves the injection system. Therefore, this method involves waste of medical fluid and requires the collection of the wasted medical fluid at the output of the injection system 100, and there may be processing errors.
[0013] Moreover, the gas still present in the injection device 110 after degassing may change the operation of the injection device, even if the gas is trapped in the injection device 110. The dosage of the medical fluid is usually controlled by the stroke of the piston of the injection device 110. Gas is compressible, and the volume change of the medical fluid within the injection device will therefore be inaccurate. In addition, the volume of the gas trapped in the injection device 110 must be small, otherwise there is a risk of it being injected into the common pipeline 102.
[0014] Therefore, there is a need for an injection system that is capable of evacuating gas quickly and every time gas is present in the injection device without requiring any operator involvement. Summary of the invention
[0015] An injection device for injecting a medical fluid from a medical fluid container into a medical tube is proposed, the injection device comprising:
[0016] - a body defining an inner space extending in a longitudinal direction between an upper end of the body and a lower end of the body, the lower end of the body comprising a medical tube interface, the medical fluid can enter the inner space from the medical fluid container through the medical tube interface, and can leave the inner space to be injected into the medical tube,
[0017] a piston arranged in the interior space and configured to travel in the interior space along the longitudinal direction, the piston delimiting an upper space and a lower space of the interior space, the lower space being configured to receive the medical liquid,
[0018] an emptying path which passes through the piston in the longitudinal direction from a lower space to an upper space of the inner space, and
[0019] a float configured to float on the medical liquid and arranged in a cavity within the emptying path between a lower portion of the emptying path and a middle portion of the emptying path, the lower portion of the emptying path being connected to the lower space, the cavity comprising at least one channel belonging to the emptying path, wherein the float is configured to travel within the cavity along the longitudinal direction between a blocking configuration in which a closed portion of the float closes the channel, thereby closing the emptying path, and an open configuration in which a closed portion 24a of the float is spaced apart from the channel, thereby opening the emptying path,
[0020] The float has a fixed inclination center, and the fixed inclination center is spaced apart from the top of the closed portion by a distance less than one-third of the height of the float.
[0021] Other preferred but non-limiting aspects of the present invention are as follows, either alone or in any technically feasible combination:
[0022] - the float is configured so that when the float floats on the medical fluid, the fixed tilt center is above the flotation line between the medical fluid and air;
[0023] - the fixed tilt center is spaced less than 0.50 cm from the top of the closed portion;
[0024] - the center of gravity of the float is above the center of buoyancy;
[0025] - the float is configured to float on the medical liquid with a floating line, and the center of gravity of the float is less than 1.0 cm from the floating line on the float;
[0026] - the float is configured so that when the float floats on the medicinal liquid, the floatation line is at least at a diameter of the float corresponding to 80% of the maximum diameter of the float;
[0027] - the float has a maximum diameter which is greater than five times the maximum diameter of the section of the closing portion closing the channel;
[0028] - the float has a center of buoyancy spaced at least 1.0 cm from the top of the enclosed portion;
[0029] - when the channel is closed by the closing portion, at least 1.0 mL of air is trapped in the cavity;
[0030] - the float comprises an upper part and a bottom part, wherein the upper part supports the closed part of the float and the upper part has a smaller diameter than the bottom part or a diameter that decreases from the bottom part;
[0031] - in the closed configuration in which the closed portion of the float closes the passage, the surface of the bottom is between 1.8 mm and 2.8 mm from the surface of the seat;
[0032] - the upper portion has a convex outer surface facing the closed portion;
[0033] - the buoy comprises a keel below the bottom;
[0034] The present invention also relates to an injection system, comprising:
[0035] - an injection device according to the invention,
[0036] - a first connector configured to be connected to a medicinal fluid container,
[0037] a medical fluid supply line configured to connect the first connector to the medical tube interface for supplying the medical fluid to the injection system,
[0038] - a common line configured to be connected to the medical tube interface and a patient line to inject the medical fluid into the patient line. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Other aspects, objects and advantages of the present invention will become more apparent on reading the following detailed description of a preferred embodiment of the invention given by way of non-limiting example and with reference to the accompanying drawings, in which:
[0040] - Figure 1 is an overall view of an injection system having two medical fluid containers connected thereto;
[0041] - Figure 2 is a cross-sectional view of a piston of an injection device during a filling step prior to degassing;
[0042] - Figure 3 is a cross-sectional view of the piston of the injection device during the start of degassing;
[0043] - Figure 4is a cross-sectional view of the piston of the injection device at the end of emptying;
[0044] - Figure 5 is a cross-sectional view of the piston of the injection device during the injection step after degassing;
[0045] - Figure 6 is a cross-sectional view of a piston according to one possible embodiment showing a float in a blocked position;
[0046] - Figure 7 is a cross-sectional view of a float according to one possible embodiment. DETAILED DESCRIPTION
[0047] The injection device of the present invention can be used as described above. Figure 1 The injection system 100. Except for the injection device 110, the injection system 100 will not be further described.
[0048] Figure 2-5 An example of an injection device having the same features as the claimed invention except for the design of the float is shown. Figure 2-5 and corresponding paragraphs in the specification to allow better disclosure of the invention, and in addition to the design of the float, Figure 2-5 Each feature disclosed in and the corresponding paragraph in the description is applicable to the claimed invention.
[0049] refer to Figure 2-5 The injection device 110 comprises a body 2, which defines an inner space 4 extending in the longitudinal direction between an upper end 2b of the body 2 and a lower end 2a of the body 2, the lower end 2a of the body having a medical tube interface 112, through which a medical liquid can enter the inner space 4 from a medical liquid container 104, and can leave the inner space 4 to be injected into a common pipeline 102. In contrast to previous injection devices, the injection device 110 according to the present invention is configured to stay downward with the medical tube interface 112. Spatial terms such as "downward", "upward", "lower", "higher", "highest" must be understood to define generally accepted relative positions relative to the vertical direction, i.e. the local earth gravity direction. This is because gases and medical liquids are subject to gravity, and the present invention utilizes gravity for proper gas evacuation. Therefore, in use, the lower end 2a of the body 2 is located below the upper end 2b of the body 2. The body 2 is typically a hollow cylinder, for example made of glass or plastic material, also known as a barrel.
[0050] The injection device 110 also includes a piston 6, which is arranged in the internal space 4 and is configured to travel in the longitudinal direction in the internal space 4, that is, between the upper end 2b of the main body 2 and the lower end 2a of the main body 2. The piston 6 defines an upper space 4b and a lower space 4a of the internal space. The lower space 4a is configured to receive a medical liquid, while the upper space 4b is not used to receive any liquid. The piston 6 provides an airtight seal between the upper space 4b and the lower space 4a. To this end, the piston 6 is provided with at least one peripheral seal 8 or 10, for example made of rubber, and preferably two peripheral seals 8, 10 are provided at different heights in the longitudinal direction. Each peripheral seal 8, 10 is pressed against the wall of the main body 2 to ensure a tight seal. As in the example shown, the peripheral seals 8, 10 can be square rings, but can also be, for example, O-rings.
[0051] Due to the tight seal provided by the piston 6, the pressure between the upper space 4b and the lower space 4a of the internal space 4 can be significantly different. The pressure in the upper space 4b is maintained at a reference pressure, which is approximately constant and substantially independent of the path of the piston 6. The reference pressure is typically atmospheric pressure, such as the pressure of the system environment. Preferably, the upper end 2b of the body 2 is at least partially open so that the pressure in the upper space 4b corresponds to atmospheric pressure, regardless of the stroke of the piston 6. In contrast, the pressure in the lower space 4a of the internal space 4 depends on the content of the lower space 4a and the stroke of the piston 6. In the following description, overpressure is a pressure higher than the reference pressure and vacuum pressure is a pressure lower than the reference pressure.
[0052] The piston 6 is connected to the piston rod 12, for example, by a protrusion 14 at the top of the piston 6, which engages in the piston rod 12. The piston rod 14 is driven by the syringe 108 and moves the piston 6 in the longitudinal direction in the inner space 4. The piston 6 can be formed by several parts assembled together. In the example shown, the piston 6 has a lower part 6a, a middle part 6b and an upper part 6c. Connectors such as screws 16 can be used to assemble the parts of the piston.
[0053] The piston 6 has an emptying path arranged inside the piston 6. The path crosses the piston 6 in the longitudinal direction from the lower space 4a of the internal space 4 to the upper space 4b. The emptying path is used to empty the gas present in the lower space 4a into the upper space 4b. Generally, the emptying path is not straight and can be closed or opened by components of the piston 6 at different points, as described below. More specifically, the emptying path includes a lower portion 17a, a middle portion 17b and an upper portion 17c. The lower portion 17a of the emptying path is connected to the lower space 4a, and the upper portion 17c of the emptying path is connected to the upper space 4c. The middle portion 17b is between the lower portion 17a and the upper portion.
[0054] The piston 6 includes a lower interface 18 defining the lower space 4a of the internal space 4, and the lower interface 18 has an inlet 20 of the emptying path. Preferably, the inlet 20 opens at the highest part of the lower interface 18 to properly empty all the gas present in the lower space against the lower interface 18 without any gas being trapped in the lower space 4a of the internal space. Preferably, the lower interface 18 has a surface with a vertex pointing to the upper end 2b of the body, and the inlet 20 of the emptying path opens at the vertex. For example, as in the depicted example, from the lower space 4a of the internal space, the lower interface 18 has a convex surface, and the inlet 20 of the emptying path opens in the middle of the lower interface 18. For example, the surface of the lower interface 18 may correspond to the surface of a cone, a truncated cone or a pyramid pointing upward. Alternatively, from the lower space 4a of the internal space, the lower interface 18 may have a concave surface, and the inlet 20 of the emptying path opens in the periphery of the lower interface 18. For example, the lower port 18 may have a groove arranged in the periphery of the lower port 18 , and the inlet 20 of the drain path may open in the groove.
[0055] The piston 6 comprises a purge valve 22 arranged in the emptying path between the middle part 17b of the emptying path and the upper part 17c of the emptying path. The purge valve 22 is configured to move between a blocking configuration in which the purge valve 22 closes the emptying path and a passing configuration in which the purge valve 22 remains open to the emptying path. The passing configuration of the purge valve 22 requires an overpressure in the middle part 17b of the emptying path relative to a reference pressure in the upper space 4b, which is caused by the piston 6 traveling toward the lower end 2a of the body 2. Since the upper space 4b is at a reference pressure (e.g., atmospheric pressure), an overpressure means a pressure higher than the reference pressure. More precisely, the overpressure required for the passing configuration of the purge valve 22 corresponds to a pressure in the middle part 17b exceeding the reference pressure in the upper space 4b and the upper part 17c of the emptying path by at least a first pressure threshold. The degassing valve 22 is configured to be in a blocking configuration when the piston 6 travels towards the upper end of the body 2 because there is no overpressure in the middle portion 17a relative to the reference pressure in the upper space 4b, but a vacuum pressure, ie a pressure lower than the reference pressure.
[0056] The piston 6 further includes a selector 24 disposed within the emptying channel between the lower portion 17a of the emptying path and the middle portion 17b of the emptying channel. The selector 24 is configured to selectively allow gas to pass through the selector 24 and travel along the emptying path from the lower portion 17a of the emptying path to the middle portion 17b. The selector 24 is also configured to selectively prevent the medical liquid from passing through the selector 24 and prevent the medical liquid from traveling along the emptying path from the lower portion 17a of the emptying path to the middle portion 17b, and thus prevent the medical liquid from traveling along the emptying path from the lower space 4a of the internal space to the upper space 4b. As a result, the lower portion 17a of the emptying path is a mixing portion configured to receive the medical liquid and the gas, while the middle portion 17b and the upper portion 17c are gas portions configured to receive only the gas.
[0057] The degassing valve 22 is arranged above the selector 24 in the longitudinal direction from the lower space 4a to the upper space 4b of the inner space. Therefore, the degassing valve 22 is arranged in the gas portion of the evacuation path and does not contact any liquid.
[0058] In the blocking configuration, the degassing valve 22 seals the vent holes 26 between the middle portion 17b and the upper portion 17c of the evacuation path. In the passing configuration, the degassing valve 22 leaves the vent holes 26 open. In the example shown, two vent holes 26 are present between the middle portion 17b and the upper portion 17c of the evacuation path. More or fewer vent holes 26 may be provided, as long as they can be sealed by the degassing valve 22.
[0059] Preferably, as depicted in the illustrated embodiment, the degassing valve 22 is an umbrella valve having a diaphragm-shaped sealing disc 22a and a valve stem 22b. The valve stem 22b engages in a hole 28 arranged in the fixed part of the piston 6 and has an enlarged lower portion having a higher cross section than the cross section of the hole 28, thereby fixing the degassing valve 22. The diaphragm-shaped sealing disc 22a is arranged above at least one vent hole 26, which is part of the emptying path and defines the middle part 17c from the upper part 17c of the emptying path. The umbrella valve can be deformable and / or can be slidably moved along the hole 28 arranged in the fixed part of the piston 6 to change the configuration (for example due to deformation of the valve stem). In the through configuration, due to the higher gas pressure in the middle part 17b, the sealing disc 22a is away from the vent hole 26, thereby allowing gas to pass through the vent hole 26. In the blocking configuration, due to the higher air pressure in the upper portion 17c of the evacuation path, the sealing disc 22a is pressed against the vent hole 26, thereby sealing the vent hole 26 and closing the evacuation path. For example, the umbrella valve may be made of a rubber-type elastomer, or of silicon.
[0060] The selector 24 is a float 24 configured to float on the medical fluid.
[0061] Now refer to Figure 2-5 A process for operating an injection device having a float 24 as a selector is described.
[0062] exist Figure 2 , the injection device 110 is shown before degassing, for example during a filling step, wherein the injection device 110 is filled with a medical liquid and an unwanted gas. During this filling step, the piston rod 12 is driven upwards, for example by a syringe 108 acting on said piston rod 12, so that the piston 6 moves in the longitudinal direction towards the upper end 2b of the body 2, i.e. upwards, within the inner space 4. The lower space 4a expands, causing the gas pressure within said lower space 4a to drop below a reference gas pressure, for example atmospheric pressure, within the upper space 4b.
[0063] Since the selector 24 allows the gas to pass from the lower part 17a of the evacuation path to the middle part 17b, a pressure reduction in the lower space 4a is also found in the lower part 17a and the middle part 17b of the evacuation path. However, since the degassing valve 22 requires an overpressure in the middle part 17b of the evacuation path in the passing configuration, the degassing valve 22 remains in the blocking configuration. More precisely, the degassing valve 22 is pressed downward, sealing the vent hole 26, thereby closing the evacuation path in the blocking configuration.
[0064] The expansion of the lower space 4a, combined with the closing of the evacuation path by the degassing valve 22, effectively creates a vacuum pressure in the lower space 4a, i.e. a pressure below the reference pressure. The pressure in the lower space 4a decreases until the opening pressure of the first tube valve 130 is reached, which is, for example, between 0.2 and 0.5 bar below the reference pressure. The opening of the first tube valve 130 creates a suction of the medical liquid to compensate for the vacuum pressure in the lower space 4a. The medical liquid is filled into the lower space 4a via the filling line 114 connected to the medical liquid container 104. The gas present in the pipeline is also sucked into the lower space 4a.
[0065] Gradually, as the lower space 4a becomes filled with medical liquid and gas, the pressure in the lower space 4a increases and becomes closer to atmospheric pressure. When the pressure in the lower space 4a reaches the closing pressure of the first tube valve 130 (substantially similar to the opening pressure), the first tube valve 130 is closed and the filling stops. At the end of the filling step, the lower space 4a is filled with a certain volume of gas 32 that is higher than a certain volume of medical liquid 34. The gas pressure in the lower space 4a is still lower than the gas pressure in the upper space 4b, because the pressure increase is stopped by closing the first tube valve 130 before the vacuum pressure is fully compensated. Therefore, the degassing valve 22 remains in the blocking configuration.
[0066] As mentioned above, after the injection device 110 is filled, the gas in the lower space 4a must be evacuated during degassing. Figure 3 As shown, this degassing is performed by driving the piston 6 downwards. The piston 6 travels in the inner space 4 in the longitudinal direction towards the lower end 2a of the body 2. The lower space 4a contracts and the gas pressure in the lower space 4a increases until the pressure difference between the gas pressure in the middle part 17b still communicating with the lower space 4a and the reference gas pressure in the upper space 4b becomes higher than the opening pressure threshold of the degassing valve 22, i.e., until the pressure difference reaches the first pressure threshold.
[0067] As described above, the degassing valve 22 is configured to move to the through configuration in response to the overpressure in the lower space 4a exceeding the reference pressure in the upper space 4b by at least the opening pressure threshold of the degassing valve 22 (e.g., the pressure difference between the overpressure and the reference pressure is between 20 and 100 mbar). Thus, the degassing valve 22 moves to the through configuration, thereby opening the evacuation path. In the example shown, the sealing disk 22a moves away from the vent hole 26, thereby opening the vent hole 26.
[0068] The gas is evacuated from the lower space 4a of the inner space 4 to the upper space 4b through the evacuation path passing through the piston 6. More specifically, the gas enters the evacuation path through the inlet 20, then travels along the lower portion 17a of the evacuation path, then travels along the middle portion 17b of the evacuation path, then passes through the vent hole 26, and finally reaches the upper space along the upper portion 17c. Figure 3 Indicated by the dotted arrow.
[0069] When the piston 6 moves downward while the gas is evacuated through the evacuation path, the piston reaches the volume of the medical liquid in the lower space 4a. More specifically, the lower interface 18 contacts the medical liquid, and since the inlet 20 opens at the highest part of the lower interface 18, the gas is pushed back toward the inlet 20 of the evacuation path. Therefore, before the medical liquid reaches the inlet 20 of the evacuation path, the gas is evacuated from the lower space 4a. When all the gas has been evacuated, the medical liquid passes through the inlet 20 in the lower interface 18 of the piston 6 and fills the lower part 17a of the evacuation path.
[0070] As shown, the lower portion 17a of the emptying path may include a cavity 36 in which the selector 24 is disposed and the medical fluid begins to fill the cavity 36. The selector is a float 24 configured to float on the medical fluid, and the cavity 36 is configured to allow the float 24 to move up and down in the cavity 36 along the longitudinal direction. The cavity 36 includes at least one channel 38 that forms a boundary between the lower portion 17a and the middle portion 17b of the emptying path. The channel 38 is disposed at the top of the cavity 36. The float 24 is configured to travel in the cavity 36 along the longitudinal direction between a blocking configuration and an open configuration, in which the float 24 closes (i.e., blocks) the channel 38, thereby closing the emptying path, and in the open configuration, the float 24 is spaced apart from the channel 36, thereby maintaining the opening and opening of the emptying path.
[0071] More precisely, when the cavity 36 is filled with gas 32, the float 24 stays at the bottom of the cavity 36, keeping the passage 38 open, thereby keeping the emptying path clear. When the medical liquid reaches the cavity 36, the float 24 begins to float on the medical liquid and is thus carried upward by the medical liquid 34 according to the upward buoyancy force exerted by the medical liquid on the float (Archimedes principle). Under the action of this force, the float 24 moves upward until it reaches the top of the cavity 36 and blocks the passage 38.
[0072] The passage 38 is defined by a periphery forming a seat 40 for the float 24, which periphery faces said float 24. The float closes the passage 38 by pressing against the seat. The seat 40 is made, for example, of metal or plastic, such as thermoplastic polyurethane, polyoxymethylene, polycarbonate, polyvinyl chloride, etc. Advantageously, the seat 40 is made of a material having an elastic modulus higher than 2500 MPa (megapascals). Preferably, the seat 40 has a cross-section that decreases in the direction of the middle portion 17b of the emptying path and, for example, has the shape of a hollow truncated cone at least in part. A reinforcing element 42, such as a washer, may be provided above the seat 40 to reinforce the seat, in particular when said seat is made of a highly deformable material.
[0073] As in Figure 6 In the described example, the float 24 has at least one closed portion 24a, which is configured to close (e.g., close or block) the passage 38. Typically, the passage 38 has a circular cross-section, and the closed portion 24a of the float 24 also has a circular cross-section. For example, the closed portion 24a of the float 10 can have an elliptical shape at least in part, or a spherical shape or a conical shape similar to a pine tree. For example, the float 24 can be just a ball. Preferably, the closed portion 24 of the float is coated with a deformable material to better seal the passage 38 when the float 24 is pressed against the seat 40.
[0074] Preferably, the float 24a has a floating portion 24b having a portion enlarged relative to the widest portion of the closed portion 24a, and the floating portion 24b supports the closed portion 24a. The float may be in two parts, such as in Figure 1-5 The float 24 may be a single component including a closed portion 24a and a floating portion 24b. The closed portion 24a of the float 24 is, for example, a sphere. The diameter of the floating portion 24b of the float 24 is larger than the widest diameter of the closed portion 24a, i.e., the sphere of the float. The larger diameter (perpendicular to the longitudinal direction) of the floating portion 24b of the float 24 makes the float 24 more sensitive to the smaller force exerted on the float 24 by the medical liquid 34. This enhanced response allows the medical liquid to push the float 24 upward as soon as it reaches the float 24, and thus ensures that no medical liquid can reach the channel 38 before the channel is closed by the float 24.
[0075] When the medical fluid 34 contacts the float 24, for example, the floating portion 24b of the float 24, the float 24 begins to float and thus moves upward until it reaches the seat 40, as shown in FIG. Figure 4 As shown. The shape of the float 24 and the shape of the seat 40 are adjusted so that a continuous seal is created when the float 24 is pressed against the seat 40. The channel 38 is now closed and neither gas nor medical liquid can pass through the closed channel 38. Between the closed channel 38 and the surface of the medical liquid 34, in the cavity 36, i.e. in the lower part of the emptying path, a small amount of gas can be collected. This small amount of gas can keep the seat dry and avoid any material from being deposited on the seat 40. This small amount can be, for example, a volume of less than 10 ml at atmospheric pressure. This small amount of air can be an amount sufficient to dry the float 24. The density of the float 24 and the complementary shapes of the closed part 24a and the seat 40 are selected to minimize the volume of trapped air while keeping the surface of the medical liquid away from the seat 40. For example, the cross-section of the seat can decrease in the direction of the middle part 17b of the emptying path.
[0076] Once the channel 38 is closed, no gas escapes from the overpressure in the lower part 17a of the evacuation path to reach the middle part 17b. As a result, the pressure in the middle part 17b above the closed channel 38 drops until the difference between the pressure in the middle part 17b and the reference pressure reaches the closing pressure threshold of the degassing valve 22, which is slightly higher than the reference pressure since the upper space 4b is at the reference pressure. For example, the closing pressure threshold of the degassing valve 22 may correspond to a positive pressure difference of 20 to 100 mbar between the pressure in the middle part 17b and the reference pressure. Preferably, the closing pressure threshold and the opening closing threshold are substantially the same, but they may also be different. As a result, the degassing valve 22 is now closed in the blocking configuration ( Figure 5). In this example, the sealing disk 22a covers the vent hole 26. The degassing step is finished. A small amount of gas 32 under a residual overpressure (i.e. slightly above the reference pressure) remains in the middle part 17b. The residual overpressure is not high enough to cause the degassing valve 22 to open the vent hole 26. This residual overpressure ensures that atmospheric pressure from the upper space 4b enters the middle part 17b of the evacuation path, thereby avoiding non-sterile air from entering the sterile area of the medical fluid circulation.
[0077] The method may comprise a supplementary filling step performed after the degassing step and before the injection step. The supplementary filling step allows the lower space 4a to be filled with an accurate prescribed volume 34 of the medicinal liquid, which is not possible in the first filling step due to incorrect volume measurements (usually based on the path of the piston 36) caused by the gas volume 32.
[0078] The method may include an injection step, wherein the piston moves in the inner space in a longitudinal direction toward the lower end 2a of the body, and wherein the medical liquid leaves the lower space of the inner space to be injected into the medical tube. When the emptying path is closed, when the piston 6 is pushed downward, the pressure in the lower space 4a increases. When the pressure in the lower space 4a reaches the opening pressure of the second tube valve 140, the second tube valve 140 opens, and the medical liquid 34 can flow out of the lower space 4a and reach the patient line 116 through the common line 102. Therefore, the medical liquid can be injected without any gas. During injection, the float 24 contacts the medical liquid.
[0079] It should be noted that the opening pressure threshold of the degassing valve 22 (i.e., the first pressure threshold) is lower than the opening pressure threshold of the second tube valve 140 (the second pressure threshold), so that when the gas is evacuated, the degassing valve 22 opens before the second tube valve 140 opens. However, during this injection step, the closure of the channel 38 by the selector (float 24) means that the pressure in the lower space 4a increases, but the pressure in the isolated middle part 17b of the evacuation path does not increase. Therefore, the degassing valve 22 remains in the blocking configuration.
[0080] As described above, the float 24 transitions between an open configuration in which the closed portion 24a of the float 24, 50 is spaced from the passage 38, thereby opening the drain path, and a blocked configuration in which the closed portion 24a of the float 24 blocks the passage 38, thereby closing the drain path.
[0081] Since the float 24 floats on the medical liquid, the closing portion 24a closes the channel 38 before the medical liquid reaches the channel 38. Air is trapped in the cavity 36. Once the closing portion 24a of the float 24 closes the channel 38, the pressure in the cavity 36 increases, which reduces the volume of trapped air and the medical liquid is closer to the closing portion 24a. Preferably, the medical liquid is kept away from the closing portion 24a of the float. If the closing portion 24a becomes wet, drops of the medical liquid may leak in the emptying path in the long run. Since the float 24 has a low weight, another risk is that the wet closing portion 24a adheres to the channel 38, for example due to surface tension. This is particularly important because different medical fluids can have different densities and the float 24 should be able to work properly with low-density medical fluids as well as high-density medical fluids.
[0082] In order to avoid any medical liquid from entering the channel 38, and preferably avoid contacting the closed part 24a, it is desirable to ensure that sufficient air is captured in the cavity 36, which can be referred to as an air cushion protecting the closed part 24a. When the channel 38 is closed by the closed part 24a, a volume of at least 1.0 mL should be confined in the cavity 36, and preferably, the volume is greater than 2.0 mL and may be greater than 3.0 mL. It can be considered that when the channel 38 is closed by the closed part 24a, the collected air is at atmospheric pressure (approximately 1013 hPa or 1 atm). However, the volume of the captured air should not be too large. Since air is compressible, too high a volume of captured air may make it difficult to manage the pressure in the lower space 4a. Preferably, when the channel 38 is closed by the closed part 24a, the volume of the captured air should be less than 10.0 mL, preferably less than 5.0 mL.
[0083] In order to have enough trapped air to keep the closed part 24a dry, it may be advantageous to reintroduce air into the cavity 36 after several injections if there is no gas to be degassed. It is possible to exploit the fact that the degassing valve 22 can leak air into the middle part 17b of the evacuation path below the degassing valve 22 at a small negative pressure (e.g. between 0 and -200 mbar) and thus into the cavity 36 through the channel 38. An air introduction step can be performed from time to time to reintroduce air into the cavity 36, for example periodically. In this step, a regenerative negative pressure is generated in the middle part 17b of the evacuation path below the degassing valve 22, for example by moving the piston 6 upwards. The regenerative negative pressure is above the opening pressure or opening pressure of the first tube valve 130 or the filling valve, and is typically above -200 mbar and below -20 mbar, for example -150 mbar. Thus, the medical liquid is not filled, but the exhaust valve 22 leaks air, which enters through the middle portion 17b of the evacuation path and enters the cavity 36 through the passage 38 which is no longer blocked by the float 24. Air is thus introduced into the cavity 36 to ensure that enough air is trapped to keep the closed portion 24 dry.
[0084] The regeneration negative pressure may not be constant, but maintained for a certain duration, such as 2 to 10 seconds, depending on the leakage rate of the degassing valve 22, to allow sufficient air to be introduced. For example, the regeneration negative pressure is maintained between the opening pressure of the first pipe valve 130 or 10% to 80% of the opening pressure, and is generally comprised of -10 to -200 mbar, preferably 50 to 180 mbar.
[0085] The center of buoyancy B (i.e., center of buoyancy) of the float 24 can also be considered to ensure that the passage 38 is blocked when the medical fluid is away from the closed portion 24a. More specifically, the center of buoyancy B of the float 24 should be spaced apart from the closed portion 24a, more precisely, the float has a center of buoyancy B that is spaced apart from the top of the closed portion 24a by more than half of the float height, preferably at least two-thirds of the float height. The center of buoyancy B of the float 24 is the center of gravity of the displaced volume of the fluid corresponding to the volume of the float 24. It is the center of the volume of the float 24.
[0086] In one aspect of the present disclosure, the buoyancy center B of the float 24 is spaced at least 1.0 cm from the top 24c of the enclosed portion 24a in the longitudinal direction, preferably at least 2.0 cm, and more preferably at least 3.0 cm. Typically, the buoyancy center B of the float 24 may be at or below one third of the height of the enclosed portion 24a from the bottom to the top of the float 24 in the longitudinal direction.
[0087] Due to the distance between the buoyancy center B and the top of the closed portion 24a, the float is pushed upward by the medical liquid toward the channel 38 earlier. The closed portion 24a of the float 24 thus closes the channel 38, while the medical liquid is at a certain distance from the closed portion 24a, and even after applying high pressure (e.g., above 15.0 bar, preferably above 20.0 bar), there is still a volume of trapped air sufficient to protect the closed portion 24a.
[0088] Stability is important because the closed portion 24a should face the channel 38 to ensure that the channel 38 is immediately closed once the closed portion 24a reaches the height of the channel 38. The float 24 has a metacenter M that is spaced from the top of the closed portion 24a by a distance less than one-third of the height of the float 24 (in the longitudinal direction), and preferably one-quarter of the height of the float 24. For example, the metacenter M is spaced from the top of the closed portion 24a by less than 1.0 cm, and preferably less than 0.50 cm. When the float 24 floats on a liquid (e.g., a density of 1, such as up to 1.44 or higher), the float 24 may tilt and the buoyancy center B of the float 24 moves. The metacenter M is the intersection of a vertical line through the tilted buoyancy center B and a line through the original vertical buoyancy center B, and the intersection is the metacenter M. Preferably, the float 24 is configured so that the metacenter is located above the floating line between the medical liquid and the air when the float 24 floats on the medical liquid.
[0089] Reference Figure 6 and Figure 7 , a non-limiting example of an injection device provided with a float to allow for trapping of sufficient air in accordance with the claimed invention is described. Figure 6 An example is shown with the float 24 in a blocked position closing the passage 38 . Figure 7 A cross-sectional view of another configuration of the float 24 is shown. The float 24 is shaped so that the center of buoyancy B is spaced apart (in the longitudinal direction) from the top 24c of the enclosed portion. Preferably, the float 24 is at least partially hollow, and preferably more hollow at the top than at the bottom. The top 24c of the enclosed portion 24a preferably has a shape that is at least partially spherical, and is generally hemispherical.
[0090] The float 24 includes, from top to bottom, a closed portion 24a, an upper portion 50, and a bottom portion 52. The upper portion 50 supports the closed portion 24a of the float 24 and has a smaller diameter than the bottom portion 52 and / or a diameter that decreases from the bottom portion 52. The diameter is measured transversely with respect to the longitudinal direction. The bottom portion 52 supports the upper portion 50. The diameter of the top portion 50 gradually increases from the closed portion 24a to the bottom portion 52. Preferably, the bottom portion 52 is heavier than the top portion 50 and the closed portion 24a.
[0091] The maximum diameter of the upper portion 50 and / or the bottom portion 52 is greater than the widest diameter of the closed portion 24a of the float. The larger diameter of the bottom portion 52 of the float 24 (perpendicular to the longitudinal direction) makes the float 24 more sensitive to smaller forces exerted on the float 24 by the medical fluid 34. This enhanced response allows the float 24 to be pushed upward as soon as the medical fluid reaches the float 24, thereby ensuring that no medical fluid can reach the passage 38 before the passage is closed by the float 24.
[0092] exist Figure 6 In the example of FIG. 5 , the upper portion 50 includes a downward middle portion 50 b and a rod 50 a protruding upward from the middle portion 50 b. Along the longitudinal direction, toward the closed portion 24 a, the cross-sectional diameter of the middle portion 50 b decreases, while the cross-sectional diameter of the upper portion 50 is substantially constant. Figure 7 As shown, there may also be a continuous diameter reduction along the upper portion 50. In this case, the upper portion may have a convex outer surface toward the closed portion 24a to help drain the medical liquid downward. The diameter of the bottom 52 may at least partially decrease downward.
[0093] The float 24 is configured so that the diameter of the floating line L when the float 24 floats on the medical liquid corresponds to at least 80% of the maximum diameter of the float 24, preferably corresponds to at least 90% of the maximum diameter of the float 24, and more preferably corresponds to the maximum diameter. The maximum diameter of the float 24 is greater than twice the maximum diameter of the portion of the closed channel 38 of the closed portion 24a, for example, greater than twice the maximum diameter of the portion of the closed portion 24a, and preferably greater than five times the maximum diameter of the portion of the closed portion 24a. For example, the maximum diameter of the float 24 can be greater than 1.5 cm, preferably greater than 2.5 cm. In these examples, the maximum diameter of the float 24 is shared by the upper portion 50 and the bottom portion 52 at their junction, but this is not required. The maximum cross-sectional diameter of the float 24 can be only at the upper portion 50 or the bottom portion 52.
[0094] In order to achieve maximum stability, the float 24 is constructed so that when the float 24 floats on the medical liquid, the floating line or water line is at the maximum diameter (perpendicular to the longitudinal direction) of the float 24, or at least at a diameter corresponding to 80% of the maximum diameter of the float 24. Here, the water line or floating line means the interface between water as the medical liquid and the air above.
[0095] The larger diameter (perpendicular to the longitudinal direction) of the float 24 makes the float 24 more sensitive to the smaller force exerted on the float 24 by the medical fluid 34. This enhanced response allows the float 24 to be pushed upward as soon as the medical fluid reaches the float 24, and thus ensures that no medical fluid can reach the passage 38 before the passage is closed by the float 24. In addition, the larger portion of the float 24 increases the force exerted by the closed portion 24a in the closed configuration and improves the tightness of the seal of the passage 38.
[0096] At least the closing portion 24a can be different and, for example, made of a semi-rigid material, such as TPE-U, TPE-S, TPE-E, silicone rubber, liquid silicone rubber or other materials with a Shore hardness comprised between 30ShA and 95ShA, more advantageously about 70ShA, while the rest of the float 24 is made of a harder material, such as PC, PA, PE, PP or other raw materials with a mechanical resistance higher between 200 and 2500MPa and more than about 800MPa. The float 24 can be made of a single piece with several materials, such as a dense plastic core at the bottom, on which a body of a low-density material such as a foam material is molded. Then, the closing portion 24a is molded on the top. The float can also be assembled from different parts. For example, the upper 50 and bottom 52 floats can be made in one piece, while the closing portion 24a is molded or added on top. The upper 50 and bottom 52 can also be different and connected together, such as Figure 7 As in the example.
[0097] The upper peripheral surface 44 of the cavity 36 is the surface of the piston 6 that defines the upper part of the cavity and opens into the seat 40 where the passage 38 is arranged. Even in the blocked configuration, the float 24 does not contact the upper peripheral surface 44 of the cavity 36. The upper peripheral surface 44 surrounds a hole 46 through which a part of the upper part 50, such as the rod 50a, engages. The hole 46 opens to the seat 40. The closed portion 24a passes over the hole 46 to the seat 40 and the passage 38. Preferably, the closed portion 24a is always above the hole 46, even in the open configuration, so that the float 24 is always correctly positioned, with the closed portion 24a facing the passage 38.
[0098] In order to further guide the float 24 towards the passage 38 , the seat 40 may have a guide portion 40 a surrounding a portion of the upper part 50 , such as the closing portion 24 a and possibly the rod 50 a , which engages outside the hole 46 .
[0099] In order to improve the efficiency of the trapped air protection of the closed portion 24a, the volume of trapped air is required to cause the medical volume to be kept at a certain distance from the closed portion 24a. Preferably, the upper portion 50 of the float 24 and the upper peripheral surface 44 of the cavity 36 have complementary shapes, so as to minimize the volume of trapped air in the gap 36a between the outer surface of the upper portion 50 and the corresponding facing upper surface of the cavity 36 ( Figure 6 ).
[0100] For example, the cross section of the cavity 36 may decrease in the direction of the channel 38, for example in the same way as the outer surface of the upper part 50. However, the gap 36a must not be too small to avoid any risk of trapping the medical fluid in the gap 36a and to avoid possible obstruction of the movement of the float 24 due to capillary action and surface tension phenomena.
[0101] Preferably, when the passage 38 is closed, the minimum or average distance D1 of the air gap 36a between the outer surface of the upper portion 50 and the corresponding upper facing peripheral surface 44 of the cavity 36 is at least 1.8 mm, and preferably at least 2.0 mm. To prevent too much trapped air, the maximum or average distance D1 of the air gap 36a between the outer surface of the upper portion 50 and the corresponding upper facing peripheral surface 44 of the cavity 36 when the passage 38 is closed is at most 3.0 mm, preferably at most 2.7 mm, and more preferably 2.5 mm. Or more generally, when the passage 38 is closed, most of the distance d1 of the air gap 36a between the outer surface of the upper portion 50 and the corresponding upper facing peripheral surface 44 of the cavity 36 is at least 1.8 mm, preferably at least 2.0 mm. When the passage 38 is closed, the air gap 36a between the outer surface of the upper portion 50 and the corresponding upper peripheral surface 44 of the cavity 36 has a distance d1 of at most 3.0 mm, preferably at most 2.7 mm, more preferably 2.5 mm. The air gap 36 preferably has rotational symmetry around the longitudinal direction. For example, the distance is measured along the normal of the outer surface of the upper portion 50 and / or the corresponding upper peripheral surface 44 of the cavity 36.
[0102] To provide stability, the float 24 should have at least a discrete axial symmetry about the longitudinal axis, and preferably the float 24 has a rotational symmetry about the longitudinal axis. Keeping the float 24 straight relative to the longitudinal axis allows the closed portion 24a to always face the channel 38. Therefore, when the float 24 is pushed upward by the medical fluid, the closed portion 24a closes the channel 38 without colliding with the seat 40 around the channel 38. To improve the stability of the float 24, the center of gravity G of the float 14 is preferably above the center of buoyancy B.
[0103] When the float 24 floats on water (density 1), and preferably even in liquids with densities as high as 1.44, such as high concentration medications, the center of gravity G of the float 24 is less than 1.0 cm, and preferably less than 0.5 cm, from the flotation line (the interface between the medical liquid and the air). Preferably, the center of gravity G of the float 24 is below the waterline. Preferably, the float has a metacentric height (i.e., the distance between the center of gravity G of the float 24 and the center of inclination M of the float 24) that is less than 2.0 cm, and preferably less than 1.5 cm, from the top of the enclosed portion 24a of the float.
[0104] The upper portion 50 may be used as a guide for guiding the closed portion 24a. To further guide the float 24 into the cavity 36, the float 24 may include a keel 56 below the bottom 52, extending longitudinally downward from the center of the bottom 52. The diameter of the keel 56 is at least five times smaller than the maximum diameter of the bottom 52. For example, the keel 56 extends along at least 0.4 cm, preferably less than 1.0 cm.
[0105] Although the present invention has been described with reference to certain preferred embodiments, it is obvious that the present invention is by no means limited thereto and that the present invention includes all technical equivalents of the described devices and combinations thereof. In particular, it will be apparent to those skilled in the art that various changes and modifications may be made without departing from the scope of the present invention as defined in the appended claims.
Claims
1. An injection device (110) for injecting a medical fluid from a medical fluid container into a medical tube, the injection device comprising: - a body (2) defining an internal space (4) extending in the longitudinal direction between an upper end (2b) of the body (2) and a lower end (2a) of the body (2), the lower end of the body comprising a medical tube interface (112), through which the medical fluid can enter the internal space (4) from the medical fluid container and can leave the internal space (4) to be injected into the medical tube (112), a piston (6) arranged in the interior space (4) and configured to travel in the interior space (4) along the longitudinal direction, the piston (6) delimiting an upper space (4b) and a lower space (4a) of the interior space, the lower space (4a) being configured to receive the medical liquid, - an emptying path which passes through the piston (6) in the longitudinal direction from the lower space (4a) to the upper space (4b) of the inner space, and - a float (24) configured to float on the medical liquid and arranged in a cavity (36) within the emptying path between a lower portion (17a) of the emptying path and a middle portion (17b) of the emptying path, the lower portion (17a) of the emptying path being connected to the lower space (4a), the cavity (36) comprising at least one channel (38) belonging to the emptying path, wherein the float (24) is configured to move within the cavity (36) along the longitudinal direction between a blocking configuration and an open configuration, in which the closed portion (24a) of the float (24) closes the channel (38), thereby closing the emptying path, and in which the closed portion (24a) of the float (24) is spaced apart from the channel (38), thereby opening the emptying path, The float (24) has a fixed tilt center (M), and when the float (24) floats on a liquid with a density between 1 and 1.44, the fixed tilt center (M) is spaced apart from the top of the closed part (24a) by a distance less than one third of the height of the float (24).
2. The injection device according to claim 1, wherein: When the float (24) floats on the medical fluid, the float (24) is configured so that the fixed tilt center (M) is located above a floating line between the medical fluid and air.
3. The injection device according to any one of claims 1 to 2, wherein: When the float (24) floats on the liquid, the center of inclination (M) is spaced less than 0.50 cm from the top of the closed portion (24a).
4. The injection device according to any one of claims 1 to 3, wherein: When the float (24) floats on the liquid, the center of gravity (G) of the float is above the center of buoyancy (B).
5. The injection device according to any one of claims 1 to 4, wherein: The float (24) is configured to float on the medical liquid with a floating line, and when the float (24) floats on the medical liquid, the center of gravity (G) of the float is less than 1.0 cm away from the floating line on the float.
6. The injection device according to any one of claims 1 to 5, wherein: The float (24) is configured such that when the float (24) floats on the medical fluid, the floatation line is at least at a diameter of the float (24) corresponding to 80% of the maximum diameter of the float (24).
7. The injection device according to any one of claims 1 to 6, wherein: The float has a maximum diameter which is greater than twice the maximum diameter of the section of the closing portion closing the passage (38).
8. The injection device according to any one of claims 1 to 7, wherein: When the float (24) floats on the liquid, the float has a buoyancy center that is spaced at least 1.0 cm from the top of the closed portion (24a).
9. The injection device according to any one of claims 1 to 8, wherein: When the channel (38) is closed by the closing portion (24a), air of a volume of at least 1.0 mL is trapped in the cavity (36).
10. The injection device according to any one of claims 1 to 9, wherein: The float comprises an upper portion and a bottom portion (52), wherein the upper portion supports the closed portion (24a) of the float and has a smaller diameter than the bottom portion (52) or a diameter that decreases from the bottom portion (52).
11. The injection device according to claim 10, wherein: In the blocking configuration in which the closing portion (24a) of the float (24) closes the passage (38), the surface of the bottom (52) is between 1.8 mm and 2.8 mm from the surface of the seat.
12. The injection device according to claim 11, wherein: The upper portion has a convex outer surface facing the closed portion (24a).
13. The injection device according to any one of claims 1 to 12, wherein: The buoy includes a keel (56) located below the bottom (52).
14. An injection system (100), comprising: - an injection device (110) according to any one of the preceding claims, - a first connector (104) configured to be connected to a medicinal fluid container (104), a medical fluid supply line (114) configured to connect the first connector (104) to the medical tube interface (112) for supplying the medical fluid to the injection system, A common line (102) configured to be connected to the medical tube interface (112) and a patient line (116) to inject the medical fluid into the patient line.
